Close button
Enquiry IconContact Us
Logo

Alopecia is a common autoimmune disorder that causes hair loss all over the body, most notably on the scalp. It usually begins with one or smaller round patches of hair loss on the scalp that is known as alopecia areata, which is the most common type of alopecia. Moreover, alopecia areata then progresses to total scalp hair loss (alopecia totalis) or total body hair loss (alopecia universalis). The majority of the time, hair falls out in small patches the size of a quarter. Most people's hair loss is limited to a few patches, though it can be more severe in some cases.

Global Alopecia Treatment Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 258 million cases and 5.16 million deaths due to coronavirus (COVID-19) were reported till November 24, 2021, across the globe.

Impact of COVID-19 on Demand and Supply of Alopecia Treatment

The COVID-19 pandemic and lockdown in various countries across the globe has impacted the financial status of businesses across all sectors including private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets. Several countries such as Thailand, Indonesia, and Singapore are facing problems with regards to transportation and distribution of healthcare products. In 2020, the COVID-19 pandemic disrupted health-care delivery around the world, including delays in cosmetic or hair care diagnosis and treatment.

Thus, impact of the Coronavirus (COVID-19) pandemic is expected to limit growth of the global alopecia treatment market during the forecast period. For instance, according to an article published in the journal of Clinical and Experimental Dermatology, on December 25, 2020, there was drop in dermatology and hair care outpatient services and appointments in England in 2020 due to COVID-19 pandemic. It was reported that during the COVID-19 lockdown, total dermatology appointments fell to 58%, first attendances to 43%, follow-ups to 51%, and day cases to 37% of pre-lockdown levels. Total appointments after the lockdown remained low, accounting for only 75% of pre-lockdown values. Between April and October of 2020, there were 484,415 (17%) fewer total appointments than during the same period in 2019.

The global alopecia treatment market is estimated to be valued at US$ 8,716.1 Mn in 2021, and is expected to exhibit a CAGR of 5.3% over the forecast period (2021-2028).

Figure 1: Global Alopecia Treatment Market Share (%) Analysis, By Drug Class, 2021

Alopecia Treatment  | Coherent Market Insights

The increasing cases of alopecia areata is expected to drive growth of the market over the forecast period.

The increasing prevalence of alopecia areata is expected to fuel growth of the global alopecia treatment market over the forecast period. For instance, according to the National Institute for Health and Care Excellence (NICE), U.K., in 2020, the estimated prevalence of alopecia in the U.K. was 15 per 10,000 people. It is known to affect people of all ages, but it is most common in childhood and adolescence. Peak incidence was observed between the ages of 15 and 29. Before the age of 21, 50-60% of men experience their first bald patch.

Research and Development activities in Alopecia treatment

Increasing number of clinical trials for the treatment of alopecia is expected to aid in the growth of the global alopecia treatment market over the forecast period. For instance, on December 02, 2020, researchers from University of Brazil conducted a randomized, placebo-controlled trial to assess the efficacy and safety of 0.5% minoxidil intradermal injections for the treatment of female androgenetic alopecia. The findings demonstrated that intradermal injections of minoxidil were more effective than placebo in the treatment of female androgenetic alopecia while also having a favorable safety profile.

CMI table icon

Alopecia Treatment Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 8,716.1 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 5.3% 2028 Value Projection: US$ 12,508.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Disease Type: Alopecia Areata, Androgenic Alopecia, Traction Alopecia, Others
  • By Drug Class: Corticosteroids, 5 AR Inhibitors, Vasodilators, Others
  • By Route of Administration: Topical, Oral, Injectable
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy’s Laboratories Ltd., Himalaya Wellness Company, Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd. 

Growth Drivers:
  • Increasing prevalence of alopecia areata
  • Increasing research and development activities
  • Increasing product launches or approvals
Restraints & Challenges:
  • Limitations associated with alopecia treatment

Restraint- Global Alopecia Treatment Market

The increasing limitations associated with certain treatments of alopecia is expected to be a major factor hampering growth of the global alopecia treatment market. For instance, according to a series of reports from the U.S. Food and Drug Administration’s (FDA’s) Patient-Focused Drug Development Initiative published in September 2017, which include the patient perspectives on treatments for alopecia areata. Many of the patients/participants who reported using corticosteroids as a treatment for alopecia said corticosteroids were frequently ineffective and had significant side effects. With these treatments, some participants reported temporary success in slowing or stopping the rate of hair loss. However, many of the participants had little or no response to corticosteroid use. Hence, corticosteroids were deemed ‘ineffective’ and ‘not a viable treatment option’ by the participants.

Global Alopecia Treatment Market – Regional Analysis

On the basis of region, global alopecia treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to be the most lucrative region in the global alopecia treatment market, owing to increasing product launches and approvals by market players based in this region. For instance, on March 16, 2020, Eli Lilly and Company, in collaboration with Incyte Corporation, announced that baricitinib has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the treatment of alopecia areata (AA), an autoimmune disorder that can cause unpredictable hair loss on the scalp, face, and other areas of the body.

Moreover, increasing research and development activities related to alopecia treatment are expected to drive the growth of the market in the Europe region. For instance, on September 10, 2021, Cassiopea SpA, an Italy-based specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and critical dermatological conditions, announced the topline results of its phase II Proof of Concept (POC) trial examining clascoterone solution for the treatment of androgenetic alopecia (AGA) in females.

Figure 2: Global Alopecia Treatment Market Value (US$ Mn), by Region, 2021

Alopecia Treatment  | Coherent Market Insights

Global Alopecia Treatment Market – Competitive Landscape

Major players operating in the global alopecia treatment market include Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy’s Laboratories Ltd., Himalaya Wellness Company, Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.

Alopecia is the medical term for hair loss. Hair loss can happen naturally or as a result of a disease or the use of certain medications. Some common types of alopecia include:

  • Androgenic alopecia is common in both men and women. It is also referred to as male- or female-pattern hair loss.
  • Alopecia areata- Alopecia areata is also known as patchy baldness. Bald patches can appear anywhere on the body, but the majority of people get a round or oval patch on the scalp.
  • Traction alopecia is caused by putting stress on the hair by pulling or stretching it repeatedly

Market Dynamics

Market players are focused on product launches or approvals, which is expected to drive growth of the global alopecia treatment market over the forecast period. For instance, in September 2021, Dr. Reddy's Laboratories Limited announced the launch of Minoxidil topical solution USP 2% and 5% for the treatment of female pattern hair loss (FPHL). Dr. Reddy's will market its products as Mintop 2 percent and Mintop Eva 5 percent, respectively. The launch comes after the Central Drugs Standard Control Organization (CDSCO) in India approved the use of Minoxidil topical solution USP 2% and 5% for the treatment of FPHL for the first time.

Market players are focused on inorganic strategies such as acquisitions, partnerships, and agreements with other market players. This is expected to drive the market growth over the forecast period. For instance, in August 2017, Aclaris Therapeutics, Inc., a biopharmaceutical company based in the U.S. acquired Confluence Life Sciences, Inc., which expanded Aclaris’ inflammation and immunology pipeline with the addition of Confluence’s lead product candidates CDD-450, topical Janus kinase inhibitors, and IL2-inducible T-cell kinase inhibitor programs.

Moreover, market players are focused on research and development activities is expected to propel the growth of the global alopecia treatment market. For instance, in August 2021, Pfizer Inc., a multinational biopharmaceutical company announced positive top-line results from the Phase 2b/3 ALLEGRO trial, which evaluated oral once-daily ritlecitinib in patients with alopecia areata, an autoimmune disease characterized by an immune attack on hair follicles that causes hair loss on the scalp and can also affect the face and body.

Key features of the study:

  • This report provides an in-depth analysis of global alopecia treatment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global alopecia treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy’s Laboratories Ltd., Himalaya Wellness Company, Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global alopecia treatment market.

Detailed Segmentation:

  • Global Alopecia Treatment Market, By Disease Type:
    • Alopecia Areata
    • Androgenic Alopecia
    • Traction Alopecia
    • Others
  • Global Alopecia Treatment Market, By Drug Class:
    • Corticosteroids
    • 5 AR Inhibitors
    • Vasodilators
    • Others
  • Global Alopecia Treatment Market, By Route of Administration:
    • Topical
    • Oral
    • Injectable
  • Global Alopecia Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Alopecia Treatment Market, By Region:
    • North America
      • By Disease Type:
        • Alopecia Areata
        • Androgenic Alopecia
        • Traction Alopecia
        • Others
      • By Drug Class:
        • Corticosteroids
        • 5 AR Inhibitors
        • Vasodilators
        • Others
      • By Route of Administration:
        • Topical
        • Oral
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Disease Type:
        • Alopecia Areata
        • Androgenic Alopecia
        • Traction Alopecia
        • Others
      • By Drug Class:
        • Corticosteroids
        • 5 AR Inhibitors
        • Vasodilators
        • Others
      • By Route of Administration:
        • Topical
        • Oral
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Disease Type:
        • Alopecia Areata
        • Androgenic Alopecia
        • Traction Alopecia
        • Others
      • By Drug Class:
        • Corticosteroids
        • 5 AR Inhibitors
        • Vasodilators
        • Others
      • By Route of Administration:
        • Topical
        • Oral
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Disease Type:
        • Alopecia Areata
        • Androgenic Alopecia
        • Traction Alopecia
        • Others
      • By Drug Class:
        • Corticosteroids
        • 5 AR Inhibitors
        • Vasodilators
        • Others
      • By Route of Administration:
        • Topical
        • Oral
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Disease Type:
        • Alopecia Areata
        • Androgenic Alopecia
        • Traction Alopecia
        • Others
      • By Drug Class:
        • Corticosteroids
        • 5 AR Inhibitors
        • Vasodilators
        • Others
      • By Route of Administration:
        • Topical
        • Oral
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Disease Type:
        • Alopecia Areata
        • Androgenic Alopecia
        • Traction Alopecia
        • Others
      • By Drug Class:
        • Corticosteroids
        • 5 AR Inhibitors
        • Vasodilators
        • Others
      • By Route of Administration:
        • Topical
        • Oral
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    •  Aclaris Therapeutics, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Fagron
    • Follicum AB
    • Cipla Inc.
    • Arcutis Biotherapeutics
    • Dr. Reddy’s Laboratories Ltd.
    • Himalaya Wellness Company
    • Eli Lilly and Company
    • Concert Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

FAQ

Frequently Asked Questions

The global alopecia treatment market is expected to exhibit a CAGR of 5.3% during the forecast period (2021-2028).

The market is estimated to be valued at US$ 8,716.1 Mn in 2021.

Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy’s Laboratories Ltd., Himalaya Wellness Company, Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd. are some of the prominent players operating in the market.

The market is expected to be valued at US$ 12,508.5 Mn in 2028.

North America is the prominent region in the market.

Increasing cases of alopecia areata, increasing research and development activities, and increasing product launches or approvals are some of the driving factors, which are expected to drive growth of the market.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.